GGrantIndex
Sort

40,608 grants matching prostate cancer

Colorectal Neoplasia in SELECT Participants

$517,442
M. Peter Lance · University Of Arizona · R01 · FY2009 · CA

Promoting Weight-loss in African American Cancer Survivors in the Deep South

$517,423
Monica L. Baskin · University Of Alabama At Birmingham · R01 · FY2014 · CA

Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer

$517,386
Samir M Hanash · University Of Tx Md Anderson Can Ctr · U01 · FY2020 · CA

Clinical trials employing cancer vaccine combination therapies

$517,380
James L. Gulley · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines

$517,380
James L. Gulley · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

A NOVEL APPROACH TO ASSAY DNA METHYLATION IN PROSTATE CANCER

$517,256
Northwestern University · · FY2013 · Department of Defense

Tumor stem cells and metastatic outcomes in mouse models of prostate cancer

$517,218
Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Assessing efficacy and implementation of an EHR tool to assess heart health among survivors

$517,124
Kathryn Elizabeth Weaver · Wake Forest University Health Sciences · R01 · FY2022 · CA

Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer

$517,115
Jose M. Garcia · Seattle Inst For Biomedical/Clinical Res · R01 · FY2025 · CA

MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER

$516,975
Marco Ruella · University Of Pennsylvania · R37 · FY2023 · CA

Role of BMP and FGF signaling during limb development

$516,943
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Developmental Core

$516,924
Elizabeth A Klonoff · San Diego State University · U54 · FY2011 · CA

NATURAL HISTORY OF PROSTATISM--THE OLMSTED COUNTY STUDY

$516,869
Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2002 · DK

A Prospective Study of Diet and Prostate Cancer

$516,807
Edward Giovannucci · Harvard School Of Public Health · P01 · FY2009 · CA

Validation of pancreatic cancer biomarkers in large prospective cohorts

$516,804
Anna E Lokshin · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · CA

MOX 1--A NOVEL MITOGENIC OXIDASE

$516,798
Emory University · R01 · FY2002 · CA

Role and targeting of PRMT5 in prostate cancer

$516,741
Chang-Deng Hu · Purdue University · R01 · FY2018 · CA

Targeting MED31-driven transcription recycling in lethal prostate cancer

$516,712
Qianben Wang · Duke University · R01 · FY2024 · CA

HUMANIN: A NOVEL THERAPEUTIC TARGET IN PROSTATE CANCER

$516,689
University Of California, Los Angeles · · FY2008 · Department of Defense

Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial

$516,583
Mona N. Fouad · University Of Alabama At Birmingham · N01 · FY2010 · CA

SAN ANTONIO CENTER OF BIOMARKERS OF RISK FOR PROSTATE CANCER (SABOR)

$516,582
Ian M Thompson · University Of Texas Hlth Science Center · M01 · FY2007 · RR

Carbohydrate Antigenic Biomarkers for Epithelial Cancers

$516,506
Minoru Fukuda Fukuda · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2012 · CA

Hybrid Plasma Markers that Complement CT Imaging for Early Lung Cancer Detection

$516,409
Paul D Lampe · Fred Hutchinson Cancer Research Center · U01 · FY2017 · CA

Decision-Making Under Uncertainty in Prostate Cancer

$516,402
University Of North Carolina Chapel Hill · R01 · FY2004 · NR

Role of BMP and FGF signaling during limb development

$516,367
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA